Satellos Bioscience MSLE
NASDAQ MSLE
$6.75 -0.45 (-6.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Satellos Bioscience (MSLE) Cash from Financing Activities (2025 - 2026)

Updated

Satellos Bioscience (MSLE) reported Cash from Financing Activities of $2.24 million for the year ended Dec 31, 2025, down 94.0% from $37.57 million a year earlier.

Analysis

Satellos Bioscience (MSLE) Cash from Financing Activities (2025 - 2026) Analysis & Trends

  • According to Business Quant data, Cash from Financing Activities came in at $37.57 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -8.53 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 6.82 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -2.43 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 6.63 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -1.53 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -2.51 Bn
10 Satellos Bioscience 109.60 Mn -98.54 Mn - 37,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37,000.00
Mar 31, 2026 51.90 Mn
Jun 30, 2025 1.39 Mn
Mar 31, 2025 2,000.00
API Access

Satellos Bioscience Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MSLE&period=max&api_key=YOUR_API_KEY